D. Hadler

Sustained efficacy and safety of idebenone in the treatment of Alzheimer’s disease: update on a 2-year double-blind multicentre study

Hans Gutzmann, D. Hadler · Journal of neural transmission. Supplementum · 1998 · 165 citations

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +11

Alzheimer’s Disease Assessment Scale: Reliability and Validity in a Multicenter Clinical Trial

Geerd Weyer, Helmut Erzigkeit, S. Kanowski et al. · International Psychogeriatrics · 1997 · 133 citations · Full text

A Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease

G. Weyer, R.M. Babej-Dölle, D. Hadler et al. · Neuropsychobiology · 1997 · 118 citations

Safety and Efficacy of Idebenone versus Tacrine in Patients with Alzheimer's Disease: Results of a Randomized, Double-Blind, Parallel-Group Multicenter Study

Hans Gutzmann, Klaus-Peter Kühl, D. Hadler et al. · Pharmacopsychiatry · 2002 · 84 citations

Efficacy Index Score, Alzheimer Type, Alzheimer's Disease +17

Randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a new isoindoline derivative (DN-2327) in generalized anxiety

Michael Linden, D. Hadler, Stefan G. Hofmann · Human Psychopharmacology Clinical and Experimental · 1997 · 59 citations

Psychotropic Medication, Psychopharmacology, Placebo-controlled Trial +24